Thomas Kean Jr, a representative for New Jersey’s 7th congressional district, recently made a new stock purchase of Abbott Laboratories (ABT) valued between $1,001 and $15,000, through the Kean Family Partnership. This move is notable as ABT is trading near its 52-week low and is considered undervalued by InvestingPro. Additionally, Kean Jr sold portions of his stakes in several companies, including General Motors (GM), Johnson & Johnson (JNJ), Markel Group Inc. (MKL), Microsoft Corporation (MSFT), and Stryker Corporation (SYK).
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Thomas Kean Jr makes strategic moves in Abbott Laboratories and General Motors
Thomas Kean Jr, a representative for New Jersey’s 7th congressional district, recently made a new stock purchase of Abbott Laboratories (ABT) valued between $1,001 and $15,000, through the Kean Family Partnership. This move is notable as ABT is trading near its 52-week low and is considered undervalued by InvestingPro. Additionally, Kean Jr sold portions of his stakes in several companies, including General Motors (GM), Johnson & Johnson (JNJ), Markel Group Inc. (MKL), Microsoft Corporation (MSFT), and Stryker Corporation (SYK).